Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10265 |
| Vaccine Name | TMV-o38 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Replicating viral vector |
| Vaccine Status | Phase 2 |
| Manufacturer | Merck & Co. Inc. |
| Year of Manufacturing | NA |
| Manufacturing Country | NA |
| Age | NA |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | Themis, Sharp & Dohme, Institute Pasteur, Univeristy of Pittsburgh |
| Other Countries | NA |
| Trade Name | V591-001—Measles-vector based |
| PMID | 33816047 |
| Clinical Trial ID | NA |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ |
| Additional Links | NA |